Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Vascul Pharmacol. 2015 Aug 1;79:24–31. doi: 10.1016/j.vph.2015.07.016

Figure 5.

Figure 5

Acute administration of SKA-31 and sodium nitroprusside (SNP) reduce systemic vascular resistance (SVR). Panel A displays absolute values for SVR recorded prior to a given drug infusion and following SKA-31 and SNP infusions at the indicated dosages. For the latter data, measurements were taken during the peak change in SVR. Panel B displays the calculated percentage change in systemic vascular resistance under each infusion condition compared with the preceding control.